SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue hovered 269.76% to Rs. 391.35 millions for the December 2025 quarter as against Rs. 105.84 millions during the corresponding quarter last year.The Total revenue for the quarter ended December 2025 of  Rs. 203.65  millions  grew by 543.44% from Rs. 31.65 millions.Operating profit surged to 279.53 millions from the corresponding previous quarter of 49.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 391.35 105.84 269.76 504.03 193.17 160.93 325.87 745.73 -56.30
Other Income 8.15 10.06 -18.99 36.38 27.41 32.73 42.07 28.15 49.45
PBIDT 279.53 49.45 465.28 316.74 81.52 288.54 169.36 222.18 -23.77
Interest 2.82 1.51 86.75 8.35 3.24 157.72 5.95 2.85 108.77
PBDT 276.71 47.94 477.20 308.39 78.28 293.96 163.41 219.33 -25.50
Depreciation 8.39 6.98 20.20 24.35 20.61 18.15 30.05 20.50 46.59
PBT 268.32 40.96 555.08 284.04 57.67 392.53 133.36 198.83 -32.93
TAX 64.67 9.31 594.63 46.31 15.78 193.47 37.62 13.46 179.49
Deferred Tax 23.55 0.42 5507.14 1.13 1.35 -16.30 1.38 -0.16 -962.50
PAT 203.65 31.65 543.44 237.73 41.89 467.51 95.74 185.37 -48.35
Equity 437.88 437.88 0.00 437.88 437.88 0.00 437.88 437.88 0.00
PBIDTM(%) 71.43 46.72 52.88 62.84 42.20 48.91 51.97 29.79 74.44

Shukra Pharma Share Price

30.28 -1.59 (-4.99%)
12-May-2026 14:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1859.90
Dr. Reddys Lab 1276.50
Cipla 1302.20
Zydus Lifesciences 935.60
Lupin 2265.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×